GB SCIENCES INC logo

GB SCIENCES INC

0001165320

GB Sciences is a plant-based research and biopharmaceutical drug development company. They create patented formulations of plant-inspired, minimum essential mixtures for prescription medications. Their focus includes therapies for Parkinson's Disease and COVID-related Cytokine Release Syndrome. They use their PhAROS AI platform to identify effective combinations of plant-based active ingredients.

90
Meget Pålitelig
Tillitsscore

Offisielt Register

MVA Nummer
593733133
Adresse
6450 CAMERON STREET #110A, LAS VEGAS, NV 89118
Bransjekoder
Crude Petroleum & Natural Gas, 1311

AI Kvalitetsanalyse

Bransje
Biopharmaceutical
SSL/HTTPS
Sikker
Profesjonell E-post
Ja
Kontakt E-post
info@gbsciences.com

🌟 Lignende Pålitelige Bedrifter

Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc. logo
82/100 · Meget Pålitelig

Kalaris is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases. They focus on innovative retinal treatments, including TH103, a potential best-in-class anti-VEGF agent for neovascular AMD. Kalaris aims to ease patient burden and improve outcomes in retinal disease management.

400 CONNELL DRIVE, USA
Se profil

Vor Biopharma Inc.

Vor Biopharma Inc. logo
80/100 · Meget Pålitelig

Vor Bio is a biopharmaceutical company focused on reinventing autoimmune disease treatment by targeting its root causes. Their lead program, telitacicept, is a potential first-in-class dual BAFF/APRIL inhibitor designed to silence survival signals of harmful B cells, aiming to halt autoantibody production. Vor Bio is committed to advancing transformative therapies that move beyond symptom control. They aspire to become a global leader in targeted autoimmune disease therapeutics.

500 BOYLSTON STREET, USA
Se profil

PUMA BIOTECHNOLOGY, INC.

PUMA BIOTECHNOLOGY, INC. logo
84/100 · Meget Pålitelig

Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer. They focus on in-licensing innovative drug candidates that have undergone clinical testing. Puma Biotechnology aims to improve cancer treatment through innovative drug development.

10880 WILSHIRE BLVD., USA
Se profil